Clinical Chase Research LLC is categorized under Medical Research in Waterbury, CT and active since 2006.
Clinical Chase Research LLC was established in 2006, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 541720 by the NAICS.
If you are seeking more information, feel free to contact Diane Rabideau at the company’s single location by writing to 500 Chase Parkway Floor 3, Waterbury, Connecticut CT 06708 or by phoning (203) 419-4420. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Clinical Chase Research LLC |
Contact Person: | Diane Rabideau |
Address: | 500 Chase Parkway Floor 3, Waterbury, Connecticut 06708 |
Phone Number: | (203) 419-4420 |
Website Address: | chasemr.com |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 2006 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Medical Research |
SIC Code: | 8733 |
NAICS Code: | 541720 |
Share This Business: |
Clinical Chase Research LLC was started in 2006 to provide professional Medical Research under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Diane Rabideau for inquiries that concern Clinical Chase Research LLC by calling the company number (203) 419-4420, as your correspondence is most welcome. Additionally, the physical location of the single location of Clinical Chase Research LLC can be found at the coordinates 41.547481,-73.062262 as well as the street address 500 Chase Parkway Floor 3 in Waterbury, Connecticut 06708.
For its online presence, you may visit Clinical Chase Research LLC’s website at chasemr.com and engage with its social media outlets through on Twitter and on Facebook.